| Previous Close | 2.71 |
| Open | 2.73 |
| Bid | 2.73 x 500 |
| Ask | 2.76 x 100 |
| Day's Range | 2.65 - 2.77 |
| 52 Week Range | 1.22 - 5.55 |
| Volume | 14,632 |
| Avg. Volume | 100,731 |
| Market Cap | 31.07M |
| Beta | -1.28 |
| PE Ratio (TTM) | -8.27 |
| EPS (TTM) | -0.33 |
| Earnings Date | May 18, 2017 - May 19, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.00 |
- ACCESSWIRE•12 days ago
Cleveland Biolabs Countermeasure for Acute Radiation Syndrome, Pipeline Review, and Market Potential
NEW YORK, NY / ACCESSWIRE / August 11, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...
- Capital Cube•19 days ago
ETFs with exposure to Cleveland BioLabs, Inc. : August 4, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cleveland BioLabs, Inc. Here are 5 ETFs with the largest exposure to CBLI-US. Comparing the performance and risk of Cleveland BioLabs, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
- Capital Cube•last month
ETFs with exposure to Cleveland BioLabs, Inc. : July 12, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cleveland BioLabs, Inc. Here are 5 ETFs with the largest exposure to CBLI-US. Comparing the performance and risk of Cleveland BioLabs, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
